Form D — Vimy Pharmaceuticals Inc.
0001493152-26-050479 · filed Nov 6, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $278,174
- Reported amount sold
- $278,174
- Minimum investment
- $0
- Investors
- 2
- Sales commission
- $10,237
- Finders' fees
- $0
Issuer
- Name
- Vimy Pharmaceuticals Inc.
- CIK
- 2159983
- Entity
- Corporation
- Jurisdiction
- ONTARIO, CANADA
- Year incorporated
- 2024
- Address
- 2 BLOOR STREET WEST
TORONTO, A6 M4W1J5 - Phone
- 416-254-4774
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
David John Suchon · Executive OfficerToronto, A6 Find on LinkedIn ↗
-
Farris Smith · Executive OfficerToronto, A6 Find on LinkedIn ↗
-
Darryl Firsten · DirectorToronto, A6 Find on LinkedIn ↗
-
Riccardo Trecroce · DirectorToronto, A6 Find on LinkedIn ↗
-
Christopher Burkett · DirectorToronto, A6 Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗